Atlas Travel Debuts Roam: An Agentic AI Travel Platform for the Modern Traveler
MARLBOROUGH, MASSACHUSETTS / ACCESS Newswire / July 21, 2025 / Atlas Travel, a leading provider of travel management services and a division of its parent company Atlas Travel & Technology Group, announced today the debut of Roam, a fully agentic AI travel booking and payment platform designed to simplify and personalize business travel at scale.
As the expectations of today's modern traveler continue to evolve, Roam was developed to meet the demand for a more intelligent, flexible and human-centered travel booking system. It blends the power of agentic, conversational AI with a secure virtual payment and treasury accounts program, making it easier for organizations to manage travel while also giving travelers the intuitive tools they want. With Roam, Atlas Travel reimagines the travel platform as one that prioritizes the traveler experience and treats personalization as a foundation, not just a feature.
'Roam represents a significant leap forward in how we approach business travel,' said Lea Cahill, President of Atlas Travel & Technology Group. 'This platform reflects our belief that great travel management should feel human, even when powered by advanced technology. Roam delivers on that promise by offering a smart, intuitive booking experience that's as powerful as it is personal.'
At its core, Roam uses an AI automation engine to understand traveler intent and preferences. In collaboration with Prime Numbers Technology, a travel analytics company and a division of Atlas Travel & Technology Group, Roam advances its recommendations even further by leveraging historical data drawn from the traveler's booking behavior to deliver curated itinerary options. Its intelligent design also streamlines travel operations, checks travel policy requirements and automates tasks end-to-end, improving efficiency for both agents and support teams.
'With Roam, we set out to solve long-standing challenges that have defined traditional travel systems for decades, like fragmented tools and one-size-fits-all models,' said Andy Piggott, CIO of Atlas Travel & Technology Group. 'The platform's agentic AI empowers travelers to book confidently and intuitively, all while giving organizations the efficiency and support they need. Roam represents a new era of travel management, built for the traveler who expects more from every journey.'
Developed in partnership with Stripe, a programmable financial services company, Roam also introduces a flexible, embedded payment experience for both travelers and travel managers. The payment feature is fully integrated with Roam's booking capabilities, offering different payment choices including prepayments and virtual card issuance. With the support of Stripe, Roam ensures enhanced security, transparency and the control needed to help finance teams manage travel spend more quickly and easily.
With the debut of Roam, Atlas Travel reinforces its commitment to delivering unparalleled service and industry-leading technology that drives innovation across the business travel industry. This platform marks a major milestone in developing solutions that prioritize advanced technology while maintaining a traveler-centric approach. Additional features and integrations are in development, with future updates aimed at further enhancing the traveler experience and streamlining travel management.
To learn more about Roam and its features and functionalities, visit getroam.ai.
***
About Atlas Travel
Since 1986, Atlas Travel has provided easier travel and better management to companies around the globe. Part of Atlas Travel & Technology Group, Atlas Travel offers corporate travel, vacation planning and meetings and incentives services. Through a wholly owned UK division and BCD Travel affiliation, Atlas Travel provides global travel programs in over 110 countries. In 2024, the company was recognized among the Top 100 Women-Led Businesses in Massachusetts by The Women's Edge and the Fastest Growing Private Companies by The Boston Business Journal. Atlas Travel is proud to be a certified Women's Business Enterprise and a B Corp business since 2021.
***
Contact Information
Shayla Peacock
Marketing Communications Manager
[email protected]
1-508-488-1223
SOURCE: Atlas Travel
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Morgan Stanley Maintains a Buy on Exelixis (EXEL) With a $48 PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the most profitable biotech stocks to invest in now. On July 22, Morgan Stanley analyst Sean Laaman maintained a Buy rating on Exelixis, Inc. (NASDAQ:EXEL) and set a price target of $48.00. A team of scientists in lab coats surrounded by pharmaceuticals and medical equipment, researching a life-saving oncology-focused biotechnology. The analyst reasoned that Exelixis, Inc. (NASDAQ:EXEL) recently updated its 2025 revenue guidance, increasing it to a $2.25-2.35 billion range after the higher-than-expected sales of Cabo. He attributed this optimistic outlook to the persistent demand growth and new patient starts in first-line renal cell carcinoma (1L RCC). Laaman also stated that Exelixis, Inc. (NASDAQ:EXEL) reported that it may update its guidance further as the NET launch progresses and additional revenue opportunities become clearer. Exelixis, Inc. (NASDAQ:EXEL) discovers, develops, and commercializes new medicines for difficult-to-treat cancers. Its product portfolio includes cabometyx, cometriq, and cotellic. While we acknowledge the potential of EXEL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
24 minutes ago
- Yahoo
The Open Group Launches The Open Group Open Digital Transformation™ Forum
Standards body aims to spur faster, more effective transformation initiatives SAN FRANCISCO, July 28, 2025--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. "The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation," commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. "By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices." Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. "Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge," said Steve Nunn, President and CEO of The Open Group. "Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment." To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. View source version on Contacts Media contact Monika BoudovaHotwire for The Open GroupUKOpengroup@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) ranks among the . RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott's strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry. According to RBC Capital's intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott's diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm's report. The less elective nature of Abbott's medical device portfolio was also mentioned by RBC as a benefit. RBC Capital's sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals. Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
